Germany

Wed
31
May

Germany: The Global Cannabis Movement Continues

Germany is becoming a hotbed for Canadian cannabis producers and we think this trend is just getting started. 

Germany, the largest country in the European Union started 2017 by legalizing medical cannabis creating a major opportunity for cannabis businesses across the world. The legislation also will make cannabis available to people suffering from serious illnesses and available through health insurance plans.

These factors have led to a surge in the number of licensed Canadian medical cannabis producers focused on this market and we want to highlight some of the recent deals.

Aurora Makes Major Acquisition

Wed
31
May

OWC Pharmaceutical Research Corp. Enters Into a Strategic Relationship With Germany-Based mediq Innovation Experts

The Initial Objective of the Collaboration is the Introduction of OWC's Active Cannabinoid-Based Topical Psoriasis Cream to the German Market.

OWC Pharmaceutical Research Corp. (OTC: OWCP) and mediq Innovation Partners (mediq) are pleased to announce an agreement for the introduction of OWCP's active cannabinoid-based topical psoriasis cream to the German market.

Frankfurt, Germany-based mediq has extensive experience, knowledge and a successful track record in enabling Israel-based companies to penetrate the European markets. mediq's objectives for OWCP will consist of both scientific collaboration and most importantly the development of a commercial market for OWCP's proprietary, active cannabinoid-based topical psoriasis cream in Germany.

Mon
29
May

Aurora Cannabis acquisition of German marijuana wholesaler could be a game changer

Aurora Cannabis Inc. (TSXV: ACB) announced just before Friday’s closing bell that it plans to acquire Germany’s Pedanios GmbH, a wholesale importer, exporter, and distributor of medical cannabis in the European Union (EU). Aurora Cannabis’ stock had been halted for more than 24 hours pending this news.

Tue
16
May

Canadian Weed Producers Will Dominate the Global Marijuana Market

“First-mover advantage.” Why Canadian weed producers will dominate the global marijuana market.

In marketing strategy, there’s a term called “first-mover advantage”. It’s when a few key players in a particular industry gain an advantage because they entered into the marketplace first. These companies are able to establish strong brand recognition, shore up the best sources of funding, and build a loyal customer base simply because there aren’t any competitors in the way during their first few years of operation. 

Mon
15
May

How German ethos and humor will shape its cannabis market

There are few places where German culture and cannabis are beginning to interact. Germans are not only accepting about this, but often find it funny. Not to mention the fact that many German firms already in this space, seem to think that all this fuss is downright humorous.

Thu
11
May

Marijuana May Boost, Rather Than Dull, the Elderly Brain

Picture the stereotypical pot smoker: young, dazed and confused. Marijuana has long been known for its psychoactive effects, which can include cognitive impairment. But new research published this week in Nature Medicine suggests the drug might affect older users very differently than young ones—at least in mice. Instead of impairing learning and memory as it does in young people, the drug appears to reverse age-related declines in the cognitive performance of elderly mice.

Tue
09
May

Daily Dose of Cannabis Extract Could Reverse Brain's Decline in Old Age, German Study Suggests

Regular low doses of THC dramatically boosted memory and learning in older mice, say scientists, who plan a clinical trial in humans later this year.

Researchers have come up with an unusual proposal to slow, or even reverse, the cognitive decline that comes with old age: small, daily doses of cannabis extract.

The idea emerged from tests on mice which found that regular, low doses of tetrahydrocannabinol (THC) – the main psychoactive ingredient in cannabis – impaired memory and learning in young animals, but boosted the performance of old ones.

Thu
04
May

German Research Group Plans Huge Study on Cannabis and Mental Health

A German research group is hoping to recruit 25,000 cannabis consumers for a study on the long-term psychological effects of cannabis use. A Berlin-based group the Research Initiative on Cannabis Consumption are currently applying for government approval for the study, as reported by The Local.

The application was first submitted to the Federal Institute for Drugs and Medical Devices in November last year, but an updated application was handed over on 19th April. Research Director, Professor Thomas Schnell, said:

Wed
03
May

Lifespot Health to Deploy Its Technology in Cannabis Vaporizers

The global medicinal cannabis market is rapidly growing.

Lifespot Health (ASX:LSH) and Seng Vital Germany will form a 50:50 joint venture in Australia to integrate the Seng Vital Cannamed vaporizer into Lifespot’s BodyTel platform.

The Cannamed vaporizer is used for the controlled delivery of cannabis to users.

Lifespot will use its BodyTel medical diagnostic and monitoring technology to assist in the administration and monitoring of cannabis use.

Tue
02
May

Report: Legal Approaches to Decriminalize Cannabis in 16 Different Countries

This report, prepared by the foreign law specialists and analysts of the Law Library of Congress, provides a review of laws adopted in Argentina, Australia, Brazil, Canada, Costa Rica, the Czech Republic, Germany, Ireland, Israel, Mexico, the Netherlands, New Zealand, Norway, Portugal, South Africa, and Uruguay with regard to decriminalization of narcotics, and touches specifically on cannabis and legalization.

Pages

Subscribe to RSS - Germany